SCHEMBL16264014

SCHEMBL16264014

COc1ccc(CC2COc3cc(OC)c(OC)cc3C2=O)cc1

nearest known ligand 0.72

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.72
MAPT P10636 3/20 0.72
MEN1 O00255 2/20 0.72
KMT2A Q03164 2/20 0.72
SMN1; SMN2 Q16637 1/20 0.72
HPGD P15428 2/20 0.65
ALOX15 P16050 2/20 0.65
ALOX12 P18054 2/20 0.65
USP2 O75604 2/20 0.65
ALDH1A1 P00352 1/20 0.65
TP53 P04637 1/20 0.65
MAOB P27338 4/20 0.54
ACHE P22303 5/20 0.49
CYP26A1 O43174 1/20 0.46
CYP24A1 Q07973 1/20 0.46
CYP19A1 P11511 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16264009 0.88 MAOB (0.64) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
Deoxysappanone B Trimethyl Ether SCHEMBL4736096 0.84 CYP3A4 (1.00) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
Deoxysappanone B Trimethyl Ether SCHEMBL29903817 0.84 CYP3A4 (1.00) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL28259502 0.83 MAOB (0.72) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL16264012 0.83 CYP3A4 (0.60) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL8463991 0.81 MAOB (0.65) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL17297291 0.80 CYP3A4 (0.83) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL8466308 0.79 CYP19A1 (0.63) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL4731838 0.79 CYP3A4 (1.00) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL29903813 0.79 CYP3A4 (1.00) CYP3A4MAPTMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014182695-A1 COMPOUNDS FOR TREATMENT OF ANGIOGENESIS-MEDIATED DISEASES INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) 2014-11-13 WO disclosed